Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Nomination Committee of XVIVO Perfusion AB (publ)
Healthcare & PharmaceuticalCompany Update

Nomination Committee of XVIVO Perfusion AB (publ)

September 5, 2025 8:45 AM

The following members have been appointed to XVIVO Perfusion's (STO:XVIVO)(LSE:0RKL)(FRA:3XV) nomination committee for the 2026 annual general meeting:Henrik Blomquist, appointed by Bure Equity ABThomas Ehlin, appointed by The Fourth Swedish National Pension FundMartin Lewin, appointed by Eccenovo ABGösta Johannesson, chairman of the board of directorsThe appointments have been made in accordance with the instructions regarding principles for...

Read more
Helping Drive Outcomes Through Community Health Engagement
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Helping Drive Outcomes Through Community Health Engagement

September 5, 2025 8:35 AM

DaVita:"It's so important to know your numbers. As someone living with diabetes and other health conditions, I hadn't had a kidney screening before, so I was really glad to get one for free today."Quote from DaVita community health eventResearch shows that Americans only go to the doctor when they feel sick.In fact, nearly two in three people have a reactive approach to their health, rather than a proactive one - making appointments only when...

Read more
Wellgistics Health, Inc. to Present at September Investor Conferences
Healthcare & PharmaceuticalConferences

Wellgistics Health, Inc. to Present at September Investor Conferences

September 5, 2025 8:30 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that Brian Norton, Chief Executive Officer, together with members of the Company's executive leadership team, will present at three upcoming investor conferences in September 2025 as follows:EVENT: H.​C. Wainwright 27th Annual Global...

Read more
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
Healthcare & PharmaceuticalProduct Announcements

Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

September 5, 2025 8:02 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, today announced that the Company's proven Thermage technology has successfully been used to perform more than 5 million skin tightening and smoothing treatments.Thermage utilizes monopolar radiofrequency energy that can safely heat layers of skin and stimulate collagen production,...

Read more
Functional Medicine is Longevity Medicine(TM) Masterclass to Redefine the Future of Healthspan
Healthcare & PharmaceuticalConferences

Functional Medicine is Longevity Medicine(TM) Masterclass to Redefine the Future of Healthspan

September 5, 2025 5:00 AM

The Functional Medicine IS Longevity Medicine™ Masterclass, hosted by Dr. Kara Fitzgerald, will convene over 30 world-renowned pioneers in functional and longevity medicine for three days of live, interactive learning, September 17-19, 2025.This free online event acknowledges, unites, and elevates the role of functional medicine in longevity science, providing healthcare professionals, policy makers, researchers, and health enthusiasts with...

Read more
Trump's DEA Must Choose: Reward Illegal Marijuana Operators or Sanction Science?
Healthcare & PharmaceuticalCompany Update

Trump's DEA Must Choose: Reward Illegal Marijuana Operators or Sanction Science?

September 5, 2025 5:00 AM

As the Trump administration touts its success in interdicting Venezuelan cartel drug shipments at sea and doubling down on border security, MMJ BioPharma Cultivation, Inc. is calling out a glaring contradiction: why should federally illegal state marijuana operators be rewarded with tax breaks, while federally compliant medical research companies like MMJ remain blocked by the DEA from conducting clinical trials? Under current law, state...

Read more
BioNxt Solutions Completes Up-Listing to The OTCQB Market
Healthcare & PharmaceuticalCompany Update

BioNxt Solutions Completes Up-Listing to The OTCQB Market

September 5, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT), is pleased to announce that the common shares of the Company (the "Common Shares") shall commence trading on the OTCQB market under the ticker symbol "BNXTF" as of September 5, 2025. The upgrade from the Company's current OTC listing makes the Common Shares available to a larger group of US investors. The Company will continue to trade on the Canadian Securities...

Read more
Dr. Kamel Foot & Ankle Expands Focus on Specialized Care for At-Risk Patients in Rancho Cucamonga
Healthcare & PharmaceuticalProduct Announcements

Dr. Kamel Foot & Ankle Expands Focus on Specialized Care for At-Risk Patients in Rancho Cucamonga

September 5, 2025 2:50 AM

Dr. Kamel Foot & Ankle has announced an expanded focus on specialized care for individuals with health conditions that increase the risk of foot complications. Diabetes, arthritis, poor circulation, and previous injuries are among the factors that make foot health more vulnerable, often leading to long-term mobility challenges if not addressed early. The announcement underscores the essential role of a foot doctor in Rancho Cucamonga in managing...

Read more
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Healthcare & PharmaceuticalRegulatory

Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

September 5, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has received notices to exercise warrants over 67,371 new ordinary shares in the Company (the "Warrant Shares").The Warrant Shares are being issued pursuant to the exercise of warrants granted and announced on 11 March 2025. Subscription monies of £235,799 have been received by the Company in respect of the exercise.Admission and Total Voting RightsApplication will be made for the...

Read more
My Compounding Pharmacy: Revolutionizing Thyroid Treatment Through Personalized Medication Solutions
Healthcare & PharmaceuticalCompany Update

My Compounding Pharmacy: Revolutionizing Thyroid Treatment Through Personalized Medication Solutions

September 4, 2025 6:20 PM

When a patient walks into their endocrinologist's office struggling with persistent thyroid symptoms despite being on "standard" medication, what options does the physician have? Too often, the answer has been limited to adjusting dosages within commercially available ranges or switching between a handful of mass-produced alternatives. But what if there was a better way?The thyroid medication landscape is undergoing a fundamental transformation,...

Read more
Avel eCare and Alliant Purchasing Bring Virtual Care Solutions to the TORCH Fall Conference in Austin, TX
Healthcare & PharmaceuticalCompany Update

Avel eCare and Alliant Purchasing Bring Virtual Care Solutions to the TORCH Fall Conference in Austin, TX

September 4, 2025 4:45 PM

Avel eCare, one of the nation's largest and most experienced telemedicine providers, will join Alliant Purchasing Group at the TORCH Fall Conference in Austin, Texas, to showcase how their partnership is expanding access to high-quality virtual care for rural and critical access hospitals.In June, Avel eCare and Alliant announced their strategic partnership to make Avel's telemedicine solutions available to Alliant's member hospitals and clinics...

Read more
Extensive Clinical and Competitive Evaluation Leads Major California University Hospital System to Standardize on Senzime's TetraGraph System
Healthcare & PharmaceuticalCompany Update

Extensive Clinical and Competitive Evaluation Leads Major California University Hospital System to Standardize on Senzime's TetraGraph System

September 4, 2025 11:50 AM

Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) today announced that one more leading university-based hospital system in California has selected Senzime's TetraGraph® as its standard of care for neuromuscular monitoring. The agreement includes an initial order of 35 TetraGraph systems that will be deployed across the system's operating rooms, supporting safe anesthesia management for more than 10,000 surgical patients annually."It's a highly...

Read more
DistillerSR Unveils Ready-to-Deploy EU-MDR Literature Review Workflows to Accelerate Notified Body Submissions
Healthcare & PharmaceuticalProduct Announcements

DistillerSR Unveils Ready-to-Deploy EU-MDR Literature Review Workflows to Accelerate Notified Body Submissions

September 4, 2025 10:00 AM

DistillerSR, the market leader in AI-enabled literature review automation and evidence management, today launched new, expert-prepared EU-MDR workflow templates designed to reduce setup time and accelerate the completion of regulatory compliant literature reviews for notified body submissions. The comprehensive range of pre-built templates provide a ready-made framework for conducting literature reviews for State-of-the-Art (SOTA), Clinical...

Read more
Medical Care Technologies Inc. (OTC PINK:MDCE) Advances Skin Cancer Prevention with AI Mole Tracking System
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC PINK:MDCE) Advances Skin Cancer Prevention with AI Mole Tracking System

September 4, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK: MDCE) is proud to announce the development of its AI-driven Mole Tracking System, a breakthrough dermatological monitoring tool for early skin cancer detection.The system uses full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-change detection to create longitudinal dermatological profiles for patients. This approach enables early identification of melanoma and other high-risk...

Read more
Affordable Access to Advanced EBOO IV Therapy: The Longevity Center FL Lowers the Barrier to Integrative Wellness
Healthcare & PharmaceuticalCompany Update

Affordable Access to Advanced EBOO IV Therapy: The Longevity Center FL Lowers the Barrier to Integrative Wellness

September 4, 2025 9:00 AM

The Longevity Center FL (LCFL) is transforming access to advanced regenerative medicine with the introduction of affordable EBOO IV Therapy through their innovative EBOOST system. Under the leadership of Dr. Benjamin Kosubevsky, this breakthrough makes cutting-edge Extracorporeal Blood Oxygenation and Ozonation therapy accessible to patients who previously faced financial barriers to advanced longevity care.EBOO IV Therapy utilizes a...

Read more
Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech's Accelerating Growth, with 45% Revenue Growth in August
Healthcare & PharmaceuticalEarnings

Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech's Accelerating Growth, with 45% Revenue Growth in August

September 4, 2025 9:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today provided an update to its shareholders about the recently released results of Sportstech Brands Holding GmbH ("Sportsech"), its pending acquisition target.Earlier today, Sportstech announced 45% YOY revenue growth for August 2025, as well as last twelve month ("LTM") performance...

Read more
GenHealth Creates 50M Public Patient Dataset
Healthcare & PharmaceuticalCompany Update

GenHealth Creates 50M Public Patient Dataset

September 4, 2025 9:00 AM

Today, we at GenHealth (https://genhealth.ai) are introducing something that will transform healthcare data access and analytics: the G-Mode 50M Synthetic Patient Dataset (https://gmode.genhealth.ai/). It's massive. We created a 50 million synthetic Medicare patients spanning over a decade of care from 2015 through 2025. Every detail is there: providers, facilities, prescriptions, procedures, costs, referrals, conditions, even the flow of care...

Read more
Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule
Healthcare & PharmaceuticalProduct Announcements

Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule

September 4, 2025 9:00 AM

Finetech, a top manufacturer of pharmaceutical machinery, launches its new technology for NJP-1200 capsule filling equipment, which achieves soft capsule+granule into one hard capsule.This capsule device is currently the only model on the Chinese market that implements this function.Finetech General Manager Tony Tao said, "Our upgraded 1200 capsule filling machine complies with cGMP standards and is equipped for both softgel and granule filling....

Read more
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
Healthcare & PharmaceuticalCompany Update

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules

September 4, 2025 8:45 AM

Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIRTMand ADAPTIR-FLEXTM platform technologies, today announced expansion of its anti-cancer pipeline with the filing of two provisional patents for trispecific candidates, APVO452 and APVO451 for prostate cancer and multiple, additional solid tumor types...

Read more
Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months
Healthcare & PharmaceuticalCompany Update

Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months

September 4, 2025 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the second interim analysis publication from its ongoing MAINSAIL™ study, a prospective, single-arm, multi-center, post-market clinical trial evaluating clinical and radiographic outcomes in adult patients with sacroiliac (SI) joint disruptions or degenerative sacroiliitis treated...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?